Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
MDXG's Cash-to-Debt is ranked higher than
90% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. MDXG: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
MDXG' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.74
MDXG's Equity-to-Asset is ranked higher than
59% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. MDXG: 0.74 )
Ranked among companies with meaningful Equity-to-Asset only.
MDXG' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44  Med: 0.79 Max: 0.89
Current: 0.74
0.44
0.89
Interest Coverage 57.55
MDXG's Interest Coverage is ranked lower than
53% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 73.23 vs. MDXG: 57.55 )
Ranked among companies with meaningful Interest Coverage only.
MDXG' s Interest Coverage Range Over the Past 10 Years
Min: 54.41  Med: 283.3 Max: No Debt
Current: 57.55
Piotroski F-Score: 4
Altman Z-Score: 18.46
Beneish M-Score: -3.03
WACC vs ROIC
6.77%
21.62%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 9.46
MDXG's Operating Margin % is ranked higher than
65% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. MDXG: 9.46 )
Ranked among companies with meaningful Operating Margin % only.
MDXG' s Operating Margin % Range Over the Past 10 Years
Min: -1334.98  Med: -4.46 Max: 13.01
Current: 9.46
-1334.98
13.01
Net Margin % 7.48
MDXG's Net Margin % is ranked higher than
62% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. MDXG: 7.48 )
Ranked among companies with meaningful Net Margin % only.
MDXG' s Net Margin % Range Over the Past 10 Years
Min: -1447.4  Med: -6.95 Max: 15.72
Current: 7.48
-1447.4
15.72
ROE % 16.20
MDXG's ROE % is ranked higher than
76% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. MDXG: 16.20 )
Ranked among companies with meaningful ROE % only.
MDXG' s ROE % Range Over the Past 10 Years
Min: -276.61  Med: -48.04 Max: 29.85
Current: 16.2
-276.61
29.85
ROA % 11.27
MDXG's ROA % is ranked higher than
79% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.49 vs. MDXG: 11.27 )
Ranked among companies with meaningful ROA % only.
MDXG' s ROA % Range Over the Past 10 Years
Min: -557.14  Med: -41.9 Max: 24.02
Current: 11.27
-557.14
24.02
ROC (Joel Greenblatt) % 49.49
MDXG's ROC (Joel Greenblatt) % is ranked higher than
81% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 6.15 vs. MDXG: 49.49 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MDXG' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2458.54  Med: -485 Max: 71.75
Current: 49.49
-2458.54
71.75
3-Year Revenue Growth Rate 52.40
MDXG's 3-Year Revenue Growth Rate is ranked higher than
96% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. MDXG: 52.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MDXG' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 26.2 Max: 261.7
Current: 52.4
0
261.7
GuruFocus has detected 3 Warning Signs with MiMedx Group Inc $MDXG.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MDXG's 30-Y Financials

Financials (Next Earnings Date: 2017-10-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

MDXG Guru Trades in Q3 2016

Joel Greenblatt 61,422 sh (+294.77%)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
» More
Q4 2016

MDXG Guru Trades in Q4 2016

John Hussman 70,000 sh (New)
Paul Tudor Jones 18,000 sh (New)
Joel Greenblatt 25,283 sh (-58.84%)
» More
Q1 2017

MDXG Guru Trades in Q1 2017

Joel Greenblatt 100,161 sh (+296.16%)
Paul Tudor Jones 31,200 sh (+73.33%)
John Hussman Sold Out
» More
Q2 2017

MDXG Guru Trades in Q2 2017

Jim Simons 486,400 sh (New)
Joel Greenblatt 830,253 sh (+728.92%)
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MDXG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-06-30 Add 728.92%0.15%$9.45 - $15.71 $ 12.27-7%830,253
Joel Greenblatt 2017-03-31 Add 296.16%0.01%$7.68 - $9.7 $ 12.2745%100,161
Joel Greenblatt 2016-12-31 Reduce -58.84%0.01%$7.85 - $9.99 $ 12.2737%25,283
Joel Greenblatt 2016-09-30 Add 294.77%0.01%$7.06 - $9.34 $ 12.2755%61,422
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3841
Compare:NAS:CNMD, NYSE:ITGR, NAS:BABY, NAS:SPNC, NAS:CSII, NAS:KTWO, NAS:XENT, NYSE:CRY, NAS:INGN, NAS:AXGN, NAS:CUTR, NAS:TCMD, NYSE:IVC, NAS:GNMK, NAS:EXAC, NAS:ARAY, NAS:VRAY, AMEX:CVRS, NAS:RTIX, NYSE:NVRO » details
Traded in other countries:MXE.Germany,
Headquarter Location:USA
MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.

MiMedx Group Inc was incorporated in Florida on February 28, 2008. The company is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants processed from human placental tissue, skin and bone. It supplies amniotic tissue products, having supplied allogrsfts in Wound Care, Burns, Surgery, Orthopedics, Spine, Sports Medicine, Ophthalmology and Dentistry.

Ratios

vs
industry
vs
history
PE Ratio 66.47
MDXG's PE Ratio is ranked lower than
89% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.71 vs. MDXG: 66.47 )
Ranked among companies with meaningful PE Ratio only.
MDXG' s PE Ratio Range Over the Past 10 Years
Min: 28.08  Med: 71.45 Max: 1843.33
Current: 66.47
28.08
1843.33
Forward PE Ratio 45.45
MDXG's Forward PE Ratio is ranked lower than
84% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 25.64 vs. MDXG: 45.45 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 66.47
MDXG's PE Ratio without NRI is ranked lower than
90% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 31.10 vs. MDXG: 66.47 )
Ranked among companies with meaningful PE Ratio without NRI only.
MDXG' s PE Ratio without NRI Range Over the Past 10 Years
Min: 28.08  Med: 71.45 Max: 1843.33
Current: 66.47
28.08
1843.33
Price-to-Owner-Earnings 70.96
MDXG's Price-to-Owner-Earnings is ranked lower than
87% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 36.31 vs. MDXG: 70.96 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MDXG' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 62.31  Med: 150 Max: 341.43
Current: 70.96
62.31
341.43
PB Ratio 9.64
MDXG's PB Ratio is ranked lower than
92% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. MDXG: 9.64 )
Ranked among companies with meaningful PB Ratio only.
MDXG' s PB Ratio Range Over the Past 10 Years
Min: 5.63  Med: 9.92 Max: 21.67
Current: 9.64
5.63
21.67
PS Ratio 5.09
MDXG's PS Ratio is ranked lower than
74% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. MDXG: 5.09 )
Ranked among companies with meaningful PS Ratio only.
MDXG' s PS Ratio Range Over the Past 10 Years
Min: 3.57  Med: 9.7 Max: 825
Current: 5.09
3.57
825
Price-to-Free-Cash-Flow 38.16
MDXG's Price-to-Free-Cash-Flow is ranked lower than
73% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.13 vs. MDXG: 38.16 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDXG' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 29.93  Med: 68.83 Max: 191.73
Current: 38.16
29.93
191.73
Price-to-Operating-Cash-Flow 33.15
MDXG's Price-to-Operating-Cash-Flow is ranked lower than
85% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 19.50 vs. MDXG: 33.15 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDXG' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 25.23  Med: 51.67 Max: 1830
Current: 33.15
25.23
1830
EV-to-EBIT 51.20
MDXG's EV-to-EBIT is ranked lower than
89% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 24.67 vs. MDXG: 51.20 )
Ranked among companies with meaningful EV-to-EBIT only.
MDXG' s EV-to-EBIT Range Over the Past 10 Years
Min: -618.7  Med: -6.4 Max: 1158.8
Current: 51.2
-618.7
1158.8
EV-to-EBITDA 42.17
MDXG's EV-to-EBITDA is ranked lower than
89% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 17.99 vs. MDXG: 42.17 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDXG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -832.5  Med: -6.2 Max: 994.2
Current: 42.17
-832.5
994.2
EV-to-Revenue 4.85
MDXG's EV-to-Revenue is ranked lower than
69% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. MDXG: 4.85 )
Ranked among companies with meaningful EV-to-Revenue only.
MDXG' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.5  Med: 9.7 Max: 714.6
Current: 4.85
3.5
714.6
Current Ratio 2.57
MDXG's Current Ratio is ranked lower than
51% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. MDXG: 2.57 )
Ranked among companies with meaningful Current Ratio only.
MDXG' s Current Ratio Range Over the Past 10 Years
Min: 0.05  Med: 2.56 Max: 7.32
Current: 2.57
0.05
7.32
Quick Ratio 2.28
MDXG's Quick Ratio is ranked higher than
53% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. MDXG: 2.28 )
Ranked among companies with meaningful Quick Ratio only.
MDXG' s Quick Ratio Range Over the Past 10 Years
Min: 0.05  Med: 2.14 Max: 7.32
Current: 2.28
0.05
7.32
Days Inventory 178.93
MDXG's Days Inventory is ranked lower than
70% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. MDXG: 178.93 )
Ranked among companies with meaningful Days Inventory only.
MDXG' s Days Inventory Range Over the Past 10 Years
Min: 11.88  Med: 129.89 Max: 178.93
Current: 178.93
11.88
178.93
Days Sales Outstanding 78.25
MDXG's Days Sales Outstanding is ranked lower than
71% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. MDXG: 78.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDXG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 74.94  Med: 99.25 Max: 104.76
Current: 78.25
74.94
104.76
Days Payable 121.92
MDXG's Days Payable is ranked higher than
81% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 54.45 vs. MDXG: 121.92 )
Ranked among companies with meaningful Days Payable only.
MDXG' s Days Payable Range Over the Past 10 Years
Min: 88.08  Med: 112.68 Max: 164.89
Current: 121.92
88.08
164.89

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.70
MDXG's 3-Year Average Share Buyback Ratio is ranked higher than
65% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. MDXG: -1.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDXG' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -105.6  Med: -24.95 Max: -1.7
Current: -1.7
-105.6
-1.7

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 17.78
MDXG's Price-to-Net-Current-Asset-Value is ranked lower than
87% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 6.83 vs. MDXG: 17.78 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
MDXG' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 11.35  Med: 19 Max: 147.5
Current: 17.78
11.35
147.5
Price-to-Tangible-Book 13.55
MDXG's Price-to-Tangible-Book is ranked lower than
91% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 3.98 vs. MDXG: 13.55 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MDXG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 10.2  Med: 16.4 Max: 316.67
Current: 13.55
10.2
316.67
Price-to-Intrinsic-Value-Projected-FCF 5.80
MDXG's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
87% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.41 vs. MDXG: 5.80 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDXG' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 5.27  Med: 11.15 Max: 354.5
Current: 5.8
5.27
354.5
Price-to-Median-PS-Value 0.52
MDXG's Price-to-Median-PS-Value is ranked higher than
82% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. MDXG: 0.52 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDXG' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.42  Med: 1.02 Max: 70
Current: 0.52
0.42
70
Price-to-Graham-Number 6.32
MDXG's Price-to-Graham-Number is ranked lower than
92% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. MDXG: 6.32 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MDXG' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 4.07  Med: 6.18 Max: 24.59
Current: 6.32
4.07
24.59
Earnings Yield (Greenblatt) % 1.95
MDXG's Earnings Yield (Greenblatt) % is ranked higher than
51% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. MDXG: 1.95 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDXG' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -19.9  Med: -0.5 Max: 3
Current: 1.95
-19.9
3

More Statistics

Revenue (TTM) (Mil) $283.32
EPS (TTM) $ 0.19
Beta0.75
Short Percentage of Float25.62%
52-Week Range $7.64 - 17.47
Shares Outstanding (Mil)112.47

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 310 350
EPS ($) 0.31 0.28
EPS without NRI ($) 0.31 0.28
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}